Annovis Bio (ANVS) Stock Soars After FDA Approval
A recent regulatory approval from the U.S. Food and Drug Administration (FDA) has led to a substantial rise in the stock price of Annovis Bio, Inc. (NYSE: ANVS). As of the latest update, ANVS shares have increased by 6.72%, trading at $8.02. This upward trajectory is largely attributed to the announcement of a successful End-of-Phase […]
Annovis Bio (ANVS) Stock Soars After FDA Approval Read More »